Arthritis drug shows promise for alopecia, restoring full hair in 20% of trial patients

Alopecia areata causes significant psychological distress and social impact for affected patients, particularly those with severe cases.

For those living with severe alopecia areata — an autoimmune condition that can strip away all hair and, with it, a measure of one's sense of self — medicine has long offered little more than sympathy. Now, a global clinical trial has found that upadacitinib, a drug already approved for rheumatoid arthritis, restored complete hair growth in one in five patients with the most difficult form of the disease, suggesting that the immune pathways driving hair loss may finally be within reach of intervention. The finding does not promise a cure for all, but it marks a rare moment when a condition lon

Arthritis drug shows promise for alopecia, restoring full hair in 20% of trial patients

Cobertura Relacionada

Recibe The Register en tu bandeja